Drug intelligence / Profile preview

acetyl-L-carnitine + nicotinamide

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

Acetyl-L-carnitine + nicotinamide is a combination of two small molecules—acetyl-L-carnitine, an acetylated form of the amino acid derivative L-carnitine, and nicotinamide (vitamin B3). Acetyl-L-carnitine facilitates the transport of fatty acids into mitochondria for β-oxidation and energy production. Nicotinamide is a precursor to NAD+, a critical coenzyme in cellular metabolism and mitochondrial function. The combination has been studied primarily in preclinical models for its potential to improve metabolic parameters, support mitochondrial health, modulate immune responses, and promote pancreatic beta-cell function. In murine models of type 1 diabetes induced by streptozotocin, this combination led to remission of hyperglycemia and restoration of insulin secretion[1]. Mechanistically, it acts by enhancing mitochondrial energy metabolism (via increased fatty acid oxidation and NAD+ synthesis), reducing oxidative stress, supporting insulin secretion from pancreatic beta cells, and modulating immune-mediated damage.

Other names
AC + Nacetyl-l-carnitine plus nicotinamide
02

Targets

CPT2 (Carnitine O-palmitoyltransferase 2)SLC25A20 (Carnitine/acylcarnitine translocase)SLC7A1 (Cationic amino acid transporter 1)NAMPT

Beyond the preview

Go deeper on acetyl-L-carnitine + nicotinamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on acetyl-L-carnitine + nicotinamide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call